• BioArctic Annual General Meeting 2021

    May 6, 2021

  • Interim Report January – September 2021

    October 21, 2021

Interim Report January - September 2021

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) published the company’s Interim Report for the period January – September 2021 on Thursday, October 21, 2021, at 08:00 a.m. CET.

Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Neurodegenerative disorders

BioArctic is committed to help people with neurodegenerative disorders

Proud partner of: